Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (320)

« Back to Publications

Optimising the monitoring and management of raised blood pressure including proteinuria testing during pregnancy: the BUMP research programme including 2 RCTs

McManus RJ. et al, (2026)

Testing a New Diabetes Adaptive Weight management Network (NewDAWN): A protocol for a randomised controlled trial

Guess N. et al, (2025), Contemporary Clinical Trials, 157

Real-world waitlist randomised controlled trial of gameChange VR to treat severe agoraphobic avoidance in patients with psychosis: A study protocol

Freeman D. et al, (2025), BMJ Open, 15

Ivermectin and COVID-19

Butler CC. et al, (2025), Journal of Infection, 91

Removal notice to “Ivermectin and COVID-19” Journal of Infection 91 (2025) 106530 (Journal of Infection (2025) 91(2), (S0163445325001240), (10.1016/j.jinf.2025.106530))

Butler CC. et al, (2025), Journal of Infection, 91

The PRINCIPLE randomised controlled open label platform trial of hydroxychloroquine for treating COVID19 in community based patients at high risk

Hobbs FDR. et al, (2025), Scientific Reports, 15

Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration

Nguyen BT. et al, (2025), Journal of Infectious Diseases, 231, e1080 - e1090

The impact of the COVID-19 pandemic on antimicrobial usage: An international patient-level cohort study

Farzana R. et al, (2025), JAC-Antimicrobial Resistance, 7

Benefits of aldosterone receptor antagonism in chronic kidney disease: the BARACK-D RCT

Hobbs FDR. et al, (2025), Health Technology Assessment, 29

Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK

Browning M. et al, (2025), Lancet Psychiatry

Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial

Harris V. et al, (2025), The Lancet Infectious Diseases, 25, 68 - 79

Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial

Farmer AJ. et al, (2024), Pilot and Feasibility Studies, 10

Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stage

Toader AM. et al, (2024), Trials, 25

Utilising primary care electronic health records to deliver the ALABAMA randomised controlled trial of penicillin allergy assessment

Ahmed S. et al, (2024), Trials, 25

Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial

Hobbs FDR. et al, (2024), Nature Medicine, 30, 3634 - 3645

Load More

1
2
3
4
5
6
7
...
»